Drug Profile
IN ASTR 001
Latest Information Update: 07 Sep 2016
Price :
$50
*
At a glance
- Originator Intas Pharmaceuticals
- Class Antidepressants
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Major depressive disorder
Most Recent Events
- 07 Sep 2016 No development reported - Phase-III for Major depressive disorder in India (PO)